Literature DB >> 21185361

Histone deacetylases in skeletal development and bone mass maintenance.

Meghan E McGee-Lawrence1, Jennifer J Westendorf.   

Abstract

The skeleton is a multifunctional and regenerative organ. Dynamic activities within the bone microenvironment necessitate and instigate rapid and temporal changes in gene expression within the cells (osteoclasts, osteoblasts, and osteocytes) responsible for skeletal maintenance. Regulation of gene expression is controlled, in part, by histone deacetylases (Hdacs), which are intracellular enzymes that directly affect chromatin structure and transcription factor activity. Key roles for several Hdacs in bone development and biology have been elucidated though in vitro and in vivo models. Recent findings suggest that clinical usage of small molecule Hdac inhibitors for conditions like epilepsy, bipolar disorder, cancer, and a multitude of other ailments may have unintended effects on bone cell populations. Here we review the progress that has been made in the last decade in understanding how Hdacs contribute to bone development and maintenance.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21185361      PMCID: PMC3046313          DOI: 10.1016/j.gene.2010.12.003

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  97 in total

1.  Deacetylation of p53 modulates its effect on cell growth and apoptosis.

Authors:  J Luo; F Su; D Chen; A Shiloh; W Gu
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

2.  Repression of Runx2 function by TGF-beta through recruitment of class II histone deacetylases by Smad3.

Authors:  Jong Seok Kang; Tamara Alliston; Rachel Delston; Rik Derynck
Journal:  EMBO J       Date:  2005-06-30       Impact factor: 11.598

3.  Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors.

Authors:  Hyun Hwa Cho; Hyung Taek Park; Yeon Jeong Kim; Yong Chan Bae; Kuen Taek Suh; Jin Sup Jung
Journal:  J Cell Biochem       Date:  2005-10-15       Impact factor: 4.429

4.  Stat3 dimerization regulated by reversible acetylation of a single lysine residue.

Authors:  Zheng-Long Yuan; Ying-Jie Guan; Devasis Chatterjee; Y Eugene Chin
Journal:  Science       Date:  2005-01-14       Impact factor: 47.728

5.  Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation.

Authors:  S K Lee; J A Lorenzo
Journal:  Endocrinology       Date:  1999-08       Impact factor: 4.736

6.  Redundant control of adipogenesis by histone deacetylases 1 and 2.

Authors:  Michael Haberland; Michele Carrer; Mayssa H Mokalled; Rusty L Montgomery; Eric N Olson
Journal:  J Biol Chem       Date:  2010-02-26       Impact factor: 5.157

7.  Histone deacetylase 3 interacts with runx2 to repress the osteocalcin promoter and regulate osteoblast differentiation.

Authors:  Tania M Schroeder; Rachel A Kahler; Xiaodong Li; Jennifer J Westendorf
Journal:  J Biol Chem       Date:  2004-08-02       Impact factor: 5.157

8.  Histone deacetylase 3 depletion in osteo/chondroprogenitor cells decreases bone density and increases marrow fat.

Authors:  David F Razidlo; Tiffany J Whitney; Michelle E Casper; Meghan E McGee-Lawrence; Bridget A Stensgard; Xiaodong Li; Frank J Secreto; Sarah K Knutson; Scott W Hiebert; Jennifer J Westendorf
Journal:  PLoS One       Date:  2010-07-09       Impact factor: 3.240

9.  Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety.

Authors:  John L Vahle; Masahiko Sato; Gerald G Long; Jamie K Young; Paul C Francis; Jeffery A Engelhardt; Michael S Westmore; Yanfei Linda; James B Nold
Journal:  Toxicol Pathol       Date:  2002 May-Jun       Impact factor: 1.902

10.  Assessment for the identification of better HDAC inhibitor class through binding energy calculations and descriptor analysis.

Authors:  Kalyanamoorthy Subha; Gopal Ramesh Kumar
Journal:  Bioinformation       Date:  2008-12-31
View more
  46 in total

1.  Histone deacetylases 2 and 9 are coexpressed and nuclear localized in human molar odontoblasts in vivo.

Authors:  Franz J Klinz; Yüksel Korkmaz; Wilhelm Bloch; Wolfgang H M Raab; Klaus Addicks
Journal:  Histochem Cell Biol       Date:  2012-02-02       Impact factor: 4.304

Review 2.  MicroRNA control of bone formation and homeostasis.

Authors:  Jane B Lian; Gary S Stein; Andre J van Wijnen; Janet L Stein; Mohammad Q Hassan; Tripti Gaur; Ying Zhang
Journal:  Nat Rev Endocrinol       Date:  2012-01-31       Impact factor: 43.330

Review 3.  Histone Deacetylases in Bone Development and Skeletal Disorders.

Authors:  Elizabeth W Bradley; Lomeli R Carpio; Andre J van Wijnen; Meghan E McGee-Lawrence; Jennifer J Westendorf
Journal:  Physiol Rev       Date:  2015-10       Impact factor: 37.312

Review 4.  Chromatin modifiers and histone modifications in bone formation, regeneration, and therapeutic intervention for bone-related disease.

Authors:  Jonathan A R Gordon; Janet L Stein; Jennifer J Westendorf; Andre J van Wijnen
Journal:  Bone       Date:  2015-03-31       Impact factor: 4.398

5.  NF-κB Has a Direct Role in Inhibiting Bmp- and Wnt-Induced Matrix Protein Expression.

Authors:  Rohinton S Tarapore; Jason Lim; Chen Tian; Sandra Pacios; Wenmei Xiao; Daniel Reid; Hancheng Guan; Marcelo Mattos; Bo Yu; Cun-Yu Wang; Dana T Graves
Journal:  J Bone Miner Res       Date:  2015-08-06       Impact factor: 6.741

Review 6.  Autophagy as a therapeutic target in cardiovascular disease.

Authors:  Andriy Nemchenko; Mario Chiong; Aslan Turer; Sergio Lavandero; Joseph A Hill
Journal:  J Mol Cell Cardiol       Date:  2011-06-23       Impact factor: 5.000

7.  SIRT6 deficiency culminates in low-turnover osteopenia.

Authors:  Toshifumi Sugatani; Olga Agapova; Hartmut H Malluche; Keith A Hruska
Journal:  Bone       Date:  2015-07-17       Impact factor: 4.398

8.  A positive role of microRNA-15b on regulation of osteoblast differentiation.

Authors:  S Vimalraj; Nicola C Partridge; N Selvamurugan
Journal:  J Cell Physiol       Date:  2014-09       Impact factor: 6.384

9.  The Deletion of Hdac4 in Mouse Osteoblasts Influences Both Catabolic and Anabolic Effects in Bone.

Authors:  Teruyo Nakatani; Tiffany Chen; Joshua Johnson; Jennifer J Westendorf; Nicola C Partridge
Journal:  J Bone Miner Res       Date:  2018-04-25       Impact factor: 6.741

Review 10.  Osteoblast dysfunctions in bone diseases: from cellular and molecular mechanisms to therapeutic strategies.

Authors:  Pierre J Marie
Journal:  Cell Mol Life Sci       Date:  2014-12-09       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.